Systemic safety of fluticasone furoate/vilanterol combination

Thorax

Volumn 68, Issue 12, 2013, Pages 1165-

  Lipworth, Brian ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATININE; FLUTICASONE FUROATE; FLUTICASONE FUROATE PLUS VILANTEROL;

ADRENAL SUPPRESSION; ASTHMA; CREATININE URINE LEVEL; DRUG ABSORPTION; DRUG HALF LIFE; DRUG RETENTION; DRUG SAFETY; FORCED EXPIRATORY VOLUME; HUMAN; HYDROCORTISONE URINE LEVEL; LETTER; LIPOPHILICITY; PRIORITY JOURNAL; SIDE EFFECT; SYSTEMIC DISEASE;

ASTHMA;

ADRENERGIC BETA-2 RECEPTOR ANTAGONISTS; ANDROSTADIENES; ASTHMA; BENZYL ALCOHOLS; CHLOROBENZENES; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE;

EID: 84887490327     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203910     Document Type: Letter

References (8)

1. Busse WW, O?Byrne PM, Bleecker ER, et al. Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the beta2 agonist vilanterol administered once daily for 52 weeks in patients =12 years old with asthma: a randomised trial. Thorax 2013;68:513-20.
2. Wilson AM, Lipworth BJ. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids. Thorax 1999;54:20-6. (Pubitemid 29103746)
3. Wilson AM, McFarlane LC, Lipworth BJ. Doseresponse effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics. Am J Respir Crit Care Med 1997;156:1274-7.
4. Fardon TC, Lee DK, Haggart K, et al. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate. Am J Respir Crit Care Med 2004;170:960-6. (Pubitemid 39425691)
5. Broide J, Soferman R, Kivity S, et al. Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 1995;80:1243-6.
6. Wilson AM, Lipworth BJ. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. Am J Med 2000;108:269-75. (Pubitemid 30110454)
7. Weiner P, Berar-Yanay N, Davidovich A, et al. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate. Chest 1999;116:931-4. (Pubitemid 29491861)
8. Allen A, Bareille PJ, Rousell VM. Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate. Clin Pharmacokinet 2013;52:37-42.